JOGO Health

JOGO Health is a commercial-stage digital therapeutics company offering an FDA-cleared EMG biofeedback platform for chronic pain and neuromuscular conditions. Its technology, rooted in foundational neuroscience research, combines wearable sensors and AI to deliver medication-free therapy, which is reimbursed by Medicare and commercial payers. The company has demonstrated clinical efficacy in trials at major institutions and operates through a network of clinics and telehealth. JOGO positions itself at the intersection of digital health, neurorehabilitation, and value-based care.

FDA-cleared EMG biofeedback system integrating wearable sensors, AI, and therapeutic software (Pain Neuroscience Education, Pain Reprocessing Therapy) to leverage neuroplasticity for non-invasive treatment.

JOGO competes with other biofeedback device companies (e.g., Myndlift, Brainmaster), digital therapeutic apps for chronic pain (e.g., Hinge Health, Kaia Health), and traditional in-clinic physical therapy/rehabilitation services. Its differentiation lies in its specific focus on EMG-based neuroplasticity, FDA clearance, and established payer coverage for a wide range of indications.